MAPKAPK5 and colorectal carcinoma: Kaplan–Meier analysis of OS showed that our CRC patients, but not the CRC patients of the TCGA cohorts, with high MK5 expression had a much worse prognosis than those with low MK5 levels (Fig. S3A).